MSI was examined for 35/43 (81%) paired blood and tumor-derived DNA samples, including those with increased MLH1 and MSH6 methylation, using five microsatellite markers: NR-21, NR-24, BAT-25, BAT-26, and MONO-27. The gene discussed is MLH1; the disease is neoplasm.